Presymptomatic diagnosis of CYP24A1-related infantile idiopathic hypercalcemia: A case report.

Eur J Med Genet

Department of Medical Genetics, "Iuliu Hatieganu" University of Medicine and Pharmacy, Cluj-Napoca, Romania; Department of Genetics, "Ion Chiricuta" Cancer Institute, Cluj-Napoca, Romania. Electronic address:

Published: December 2020

Vitamin D plays an important role in calcium homeostasis and bone mineralization. Inefficient inactivation of vitamin D leads to a condition called idiopathic infantile hypercalcemia (IIH). In the last decade mutations in CYP24A1, the gene responsible for vitamin D inactivation, were described as the main molecular cause of IIH. In this study, we present a family with two daughters diagnosed with IIH due to two different mutations in CYP24A1 gene. Based on next-generation sequencing (NGS), the elder daughter was diagnosed as carrying the mutations CYP24A1: c.1186C > T; (p.Arg396Trp) and c.428_430del; (p.Glu143del). Within this context, we were able to presymptomatically diagnose her newborn sister using Sanger sequencing technique. Screening for CYP24A1 mutations in families with IIH history helps preventing disease manifestations in newborn siblings. Thus, NGS combined with Sanger sequencing validation opens up the perspective of preventive medicine with great impact on IIH management, where stopping vitamin D administration is enough to prevent disease manifestation, in most cases.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejmg.2020.104100DOI Listing

Publication Analysis

Top Keywords

mutations cyp24a1
12
cyp24a1 gene
8
sanger sequencing
8
iih
5
presymptomatic diagnosis
4
diagnosis cyp24a1-related
4
cyp24a1-related infantile
4
infantile idiopathic
4
idiopathic hypercalcemia
4
hypercalcemia case
4

Similar Publications

Decoding the prognostic landscape of LUAD: the interplay between N-methyladenosine modification and immune microenvironment.

Front Immunol

December 2024

State Key Laboratory of Trauma and Chemical Poisoning, Department of Stem Cell and Regenerative Medicine, Daping Hospital, Army Medical University, Chongqing, China.

Background: To determine the role of N-methyladenosine (mA) modification in the tumor immune microenvironment (TIME), as well as their association with lung adenocarcinoma (LUAD).

Methods: Consensus clustering was performed to identify the subgroups with distinct immune or mA modification patterns using profiles from TCGA. A risk score model was constructed using least absolute shrinkage and selection operator regression and validated in two independent cohorts and LUAD tissue microarrays.

View Article and Find Full Text PDF

Regulatory mechanisms and pathological implications of CYP24A1 in Vitamin D metabolism.

Pathol Res Pract

December 2024

Department of Biotechnology, School of Bioengineering, SRM Institute of Science and Technology, Kattankulathur, Tamil Nadu 603 203, India. Electronic address:

CYP24A1 is a crucial gene within the cytochrome P450 superfamily, responsible for encoding the enzyme 25-hydroxyvitamin D3-24-hydroxylase. This enzyme is involved in the catabolism of 1,25-dihydroxyvitamin D3, the biologically active form of vitamin D3, by hydroxylating its side chain. Through this process, CYP24A1 tightly regulates the bioavailability and physiological impact of vitamin D3 in the body.

View Article and Find Full Text PDF
Article Synopsis
  • Inactivation of the 24-hydroxylase enzyme (CYP24A1) in mice led to increased levels of calcitriol, resulting in higher intestinal calcium absorption and mild to severe hypercalcemia during pregnancy and lactation.
  • Both wild-type and Cyp24a1 null mice saw similar increases in bone mineral content during late pregnancy, but Cyp24a1 nulls had significantly higher calcitriol and intestinal calcium absorption, with some null dams experiencing late gestational mortality.
  • Despite some negative effects, Cyp24a1 nulls showed reduced bone loss during lactation compared to wild-types, highlighting the need for treatment options that target calcitriol levels in
View Article and Find Full Text PDF

CYP24A1 is a multifunctional, P450 mitochondrial enzyme that catabolizes the vitamin D hormone (calcitriol, 1,25(OH)2D3), its precursor (calcifediol, 25(OH)D3), and numerous vitamin D metabolites. In the kidney, Cyp24a1 is induced by 1,25(OH)2D3 and fibroblast growth factor 23 (FGF23) and potently suppressed by PTH to control the circulating levels of 1,25(OH)2D3. Cyp24a1 is controlled by a pair of promoter proximal (PRO) vitamin D response elements (VDREs) that are aided by distal, downstream (DS) enhancers.

View Article and Find Full Text PDF

CYP24A1 is a multifunctional, P450 mitochondrial 24-hydroxylase enzyme that is responsible for catabolism of the most active vitamin D hormone (calcitriol, 1,25(OH)D), its precursor (calcifediol, 25(OH)D), and numerous other vitamin D metabolites at the 23- and 24-carbon positions. In the kidney, is induced by 1,25(OH)D, induced by FGF23, and potently suppressed by PTH to tightly control the circulating blood levels of 1,25(OH)D. This gene is believed to be under the control of a pair of classic promoter proximal (PRO) vitamin D response elements (VDREs) that are aided by distal, downstream (DS) containing enhancers that we identified more recently.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!